Toggle search
Toggle menu
4.1K
4K
440
61K
ProleWiki
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Eli Lilly and Company: Difference between revisions

From ProleWiki, the proletarian encyclopedia
More languages
More actions
VisualWikitext
(Added Prozac Jury corruption case.)
mNo edit summary
Line 6: Line 6:
| founded = 1876
| founded = 1876
| key_people = David A. Ricks <small>([[Chairperson]], [[President (corporate title)|President]], & [[Chief Executive Officer|CEO]])</small><br />
| key_people = David A. Ricks <small>([[Chairperson]], [[President (corporate title)|President]], & [[Chief Executive Officer|CEO]])</small><br />
Anat Ashkenazi <small>([[Vice president]] & [[CFO]])<ref>{{News citation|title-url=https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|date=9 February 2021|access-date=20 February 2021|author=Jaimy Lee|newspaper=Market Watch|title=Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees|archive-date=9 February 2021|archive-url=https://web.archive.org/web/20210209212406/https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|url-status=live}}</ref></small>
Anat Ashkenazi <small>(Vice president & [[CFO]])<ref>{{News citation|title-url=https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|date=9 February 2021|access-date=20 February 2021|author=Jaimy Lee|newspaper=Market Watch|title=Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees|archive-date=9 February 2021|archive-url=https://web.archive.org/web/20210209212406/https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|url-status=live}}</ref></small>
| industry = [[Pharmaceutical industry]]
| industry = [[Pharmaceutical industry]]
| products = [[Pharmaceutical drugs]]
| products = [[Pharmaceutical drugs]]
| revenue = {{Increase}} US$22.319 billion {{small|(2019)<ref name="Eli 19">{{Citation|title-url=https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def|title=Eli Lilly and Company 2019 Annual Report | newspaper=Eli Lilly | date=19 February 2020 | access-date=21 December 2020 | archive-date=1 August 2022 | archive-url=https://web.archive.org/web/20220801022704/https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def}}</ref>}}
| revenue = +US$22.319 billion {{small|(2019)<ref name="Eli 19">{{Citation|title-url=https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def|title=Eli Lilly and Company 2019 Annual Report | newspaper=Eli Lilly | date=19 February 2020 | access-date=21 December 2020 | archive-date=1 August 2022 | archive-url=https://web.archive.org/web/20220801022704/https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def}}</ref>}}
| net_income = {{Increase}} US$8.318 {{small|(2019)<ref name="Eli 19" />}}
| net_income = +US$8.318 {{small|(2019)<ref name="Eli 19" />}}
| total_assets = {{Decrease}} US$39.286 {{small|(2019)<ref name="Eli 19" />}}
| total_assets = -US$39.286 {{small|(2019)<ref name="Eli 19" />}}
| location = [[Indianapolis, Indiana]], [[United States]]
| location = [[Indianapolis, Indiana]], [[United States]]
| ownership = [[Lilly Endowment]], 11.6%<ref name="auto">{{Citation|title-url=https://www.sec.gov/Archives/edgar/data/59478/000005947821000090/llypre14a2021.htm#i91a834f8fe29450c9f0cc1a4c4cc95aa_67|title=Document}}</ref>
| ownership = [[Lilly Endowment]], 11.6%<ref name="auto">{{Citation|title-url=https://www.sec.gov/Archives/edgar/data/59478/000005947821000090/llypre14a2021.htm#i91a834f8fe29450c9f0cc1a4c4cc95aa_67|title=Document}}</ref>

Revision as of 17:08, 8 September 2022

Eli Lilly and Company
File:Eli Lilly and Company.svg
IndustryPharmaceutical industry
FounderEli Lilly
Key peopleDavid A. Ricks (Chairperson, President, & CEO)
Anat Ashkenazi (Vice president & CFO)[1]
OwnershipLilly Endowment, 11.6%[2]
Revenue+US$22.319 billion (2019)[3]
Net income+US$8.318 (2019)[3]
Total assets-US$39.286 (2019)[3]
Website
www.lilly.com


Eli Lilly and Company, often shortened to Eli Lilly, is a U.S-based pharmaceutical corporation.

Prozac Jury corruption

On July 20, 2019; Eli Lilly was found to have bribed the Jury and victims of mass shootings 20 million dollars, in multiple lawsuits against Eli Lily for murder from Prozac, to hide evidence of Prozac increasing the rate of mass shooting.[4]

References

  1. ↑ Jaimy Lee (9 February 2021). Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees Market Watch. Archived from the original on 9 February 2021.
  2. ↑ Document.
  3. ↑ 3.0 3.1 3.2 Eli Lilly and Company 2019 Annual Report (19 February 2020).
  4. ↑ Andrew Wolfson (2019-09-12T12:33Z−07:00). "Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say"
Retrieved from "https://en.prolewiki.org/index.php?title=Eli_Lilly_and_Company&oldid=16935"